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Dominant Mutations in KAT6A Cause Intellectual
Disability with Recognizable Syndromic Features
Emma Tham,1,2,* Anna Lindstrand,1,2 Avni Santani,3,4 Helena Malmgren,1,2 Addie Nesbitt,3
Holly A. Dubbs,5 Elaine H. Zackai,5 Michael J. Parker,6 Francisca Millan,7 Kenneth Rosenbaum,8
Golder N. Wilson,9,10,11 and Ann Nordgren1,2,11
Through a multi-center collaboration study, we here report six individuals from five unrelated families, with mutations in KAT6A/MOZ
detected by whole-exome sequencing. All five different de novo heterozygous truncating mutations were located in the C-terminal
transactivation domain of KAT6A: NM_001099412.1: c.3116_3117 delCT, p.(Ser1039*); c.3830_3831insTT, p.(Arg1278Serfs*17);
c.3879 dupA, p.(Glu1294Argfs*19); c.4108G>T p.(Glu1370*) and c.4292 dupT, p.(Leu1431Phefs*8). An additional subject with a 0.23
MB microdeletion including the entire KAT6A reading frame was identified with genome-wide array comparative genomic hybridiza-
tion. Finally, by detailed clinical characterization we provide evidence that heterozygous mutations in KAT6A cause a distinct intellec-
tual disability syndrome. The common phenotype includes hypotonia, intellectual disability, early feeding and oromotor difficulties,
microcephaly and/or craniosynostosis, and cardiac defects in combination with subtle facial features such as bitemporal narrowing,
broad nasal tip, thin upper lip, posteriorly rotated or low-set ears, and microretrognathia. The identification of human subjects comple-
ments previous work from mice and zebrafish where knockouts of Kat6a/kat6a lead to developmental defects.Intellectual disability (ID) or global developmental delay
occurs in 1%–3% of all children. Copy-number variations
and rare inherited (often X-linked or autosomal-recessive)
conditions explain up to 25% of all cases. With massive
parallel DNA sequencing, de novo heterozygous mono-
genic mutations have emerged as a major cause of different
intellectual disability syndromes and are responsible for up
to 40% of severe ID.1,2 Mutations in several genes involved
in the epigenetic regulation of gene expression have been
linked to different ID-syndromes including K(lysine)
acetyltransferases (e.g., KAT6B [MIM 605880]), histone
deacetylases (e.g., HDAC8 [MIM 300269]), or chromatin
remodelers (such as ATRX [MIM 300032])3). Here we report
the identification of mutations in histone K(lysine)
acetyltransferase KAT6A [MIM 601408] by multi-center
clinical diagnostic whole-exome sequencing of individuals
with ID.
Five unrelated individuals with intellectual disability,
hypotonia, feeding difficulties, cardiac defects, craniosy-
nostosis, and distinct facial features were subjected to clin-
icalWES in an attempt to identify the genetic cause of their
intellectual disability syndrome (Figure 1, Table 1). All five
were investigated and sequencing was ordered by four
different hospitals: the Karolinska University Hospital,
Children’s Hospital of Philadelphia, Children’s National
Medical Center, and Medical City Hospital.
DNAwas isolated from peripheral blood by standard pro-
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The Ame5 and subject 4 (II-2 in family 3, Figure 2C) from family 3
was sequenced as a single individual. For each subject,
the parents provided written informed consent for WES.
Individual 1 (II-1 in family 1, Figure 2A) was sequenced
as part of a combined clinical/research project that was
approved by the Ethics Committee of Karolinska Institu-
tet/Karolinska University Hospital (Dnr 2012/2106-31/4).
Coding sequences were prepared and captured with the
Agilent SureSelect All Exon kit -v4 for subjects 1, 4, 5
(II-1 in family 4, Figure 2D) and 6 (II-1 in family 5,
Figure 2E) and v5 for subject 3 (II-2 in family 2,
Figure 2B) and sequenced on an Illumina HiSeq 2500
instrument in high output mode (2 3 100 bp) at either
Oxford Gene Technology (OGT; Begbroke Science Park;
subject 1), Children’s Hospital of Philadelphia (subject 3)
or GeneDx (subjects 4, 5, and 6). WES sequence data was
mapped to the published human genome build UCSC
hg19 reference genome using Burrows-Wheeler Aligner.
Sequence variants were filtered for frequency and location
using OGT software (subject 1); Cartagenia Bench Lab NGS
software (subject 3) and GeneDx’s XomeAnalyzer (subject
4–6). The average depth of coverage of the sequenced
individuals and the average percentage of the exome that
displayed at least 103 coverage was as follows: subject 1,
703/98.5%; subject 3, 1103/98.7%; subject 4, 783/
96.6%; subject 5, 1043/96.5%; and subject 6, 1863/
98.8%. Detected variants were selected for further analysis
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Figure 1. Facial Characteristics of the Individuals with KAT6A Mutations
Individuals with KAT6Amutations show distinct facial features. Subject 2 at 22 months (A) and 9 years (B); subject 3 at 22 months (C)
and 9 years (D); subject 4 at 4 months (E) and 12months of age (F); subject 5 at 10 months (G) and 4 years 4 months of age (H); subject 6
at 5months (I) and 3.5 years (J); and subject 7 at 17 years (K and L). There are common features in all affected individuals, e.g., bitemporal
narrowing, broad nasal tip, low-set ears, thin upper lip, and/or tentedmouth, although other features such as ptosis, downturned corners
of the mouth, micrognathia, and smooth philtrum can only be seen in a subset of the subjects. See Table S1 for more details.and compound heterozygous) inheritance. Targeted anal-
ysis did not identify a causal mutation in any gene present
in the OMIM database and was therefore followed by a
complete analysis of all coding regions.
The combined results showed de novo truncating muta-
tions in KAT6A in all five affected individuals analyzed by
WES (Figure 2). Four of the five detected KAT6Amutations
were frameshift mutations caused by small insertions/
deletions (indels): NM_001099412.1: c.3116_3117 delCT
(p.Ser1039*) in individual 3 (II-2 in family 2, Figure 2B);
c.3830_3831insTT (p.Arg1278Serfs*17) in individual 6 (II-1
in family 5, Figure 2E); c.3879 dupA (p.Glu1294Argfs*19)
in individual 1 (II-1 in family 1, Figure 2A) and c.4292
dupT (p.Leu1431Phefs*8) in individual 4 (II-2 in family 3,
Figure 2C). The fifth subject (II-1 in family 4, Figure 2D)
also had a truncating mutation in KAT6A that was caused
by a nonsense change: c.4108G>T (p.Glu1370*). All
detected variants in KAT6A were verified by Sanger
sequencing. Individual 2 (II-1 in family 2, Figure 2B) had
the same c.3116_3117 delCT KAT6A mutation found in
her twin as shown by targeted Sanger sequencing. In sum-
mary, all six affected individuals harbored heterozygous
de novo, truncating mutations in KAT6A that are unlikely
to be benign variants (Table 1).
Next we browsed the DECIPHER database and identi-
fied an additional individual with a 0.23 MB deletion
on chromosome 8, arr8p11.21(41786230–42022328)31,
NCBI build 37 (individual 7, II-1 in family 6, Figure 2F;
DECIPHER ID 271144; data not shown). The deletion
had been identified by array comparative genomic hybrid-
ization (array CGH) at the Sheffield Diagnostic Genetic
Services Laboratory (Sheffield Children’s NHS Foundation
Trust) using a genome-wide design from BlueGnome (Blug-
nome 60k v2). The finding was confirmed by fluorescent
in situ hybridization (FISH) using the BlueGnome RP11-508 The American Journal of Human Genetics 96, 507–513, March 5564G13 probe. Blood samples from both parents were
also analyzed by FISH with the same probe and showed a
normal signal pattern indicating that the deletion had
occurred de novo in individual 7 (Figure 2). Two genes
were affected by the heterozygous de novo deletion
including the entire reading frame of KAT6A and two
thirds of AP3M2 (MIM 610469). Mutations in the latter
gene have not been associated with a clinical phenotype.
To further delineate the phenotype of the KAT6A muta-
tions, we focused our attention on the clinical findings in
affected individuals. None had any family history of a
similar phenotype (apart from the monozygotic twins in
family 2; Figure 2B). Briefly, the subjects share several char-
acteristics including hypotonia, developmental delay,
early feeding and oromotor problems, microcephaly and/
or craniosynostosis, and cardiac defects including patent
ductus arteriosus (PDA) and atrial septal defect (ASD)
(Table 1). Furthermore, they have subtle facial manifesta-
tions with resemblances including bitemporal narrowing,
broad nasal tip, thin upper lip, posteriorly rotated or low-
set ears, and microretrognathia (Figure 1). The detailed
clinical information of all individuals with KAT6A muta-
tions is provided in Table 1 and Table S1.
Six individuals were delivered by emergency cesarean
section, and four showed severe life-threatening neonatal
problems including respiratory distress and/or low Apgar
scores. Five out of seven subjects had congenital heart de-
fects (CHD), four of which needed surgical reparation. The
most common CHDs were atrial septal defects (four),
persistent ductus arteriosus (five), while ventricle septal
defect and persistent foramen ovale was found in one sub-
ject each.
During the neonatal period, hypotonia was evident in
six individuals (subjects 1–6) and three individuals (sub-
jects 2, 3, and 5) were initially tested for Prader-Willi, 2015
Table 1. Major Characteristics of Individuals with KAT6A Mutations
Characteristic
Individual 1 (II-1),
Family 1
Individual 2 (II-1)
(Twin A), Family 2
Individual 3 (II-2)
(Twin B), Family 2
Individual 4 (II-2),
Family 3
Individual 5 (II-1),
Family 4
Individual 6 (II-1),
Family 5
Individual 7 (II-1),
Family 6
KAT6A mutation/ exon c.3879 dupA
p.Glu1294Argfs*19
exon 18
c.3116_3117 delCT
p.Ser1039*
exon 17
c.3116_3117 delCT
p.Ser1039*
exon 17
c.4292 dupT
p.Leu1431Phefs*8
exon 18
c.4108G>T
p.Glu1370*
exon 18
c.3830_3831insTT
p.Arg1278Serfs*17
exon 18
arr 8p11.21
(41,786,230-42,022,328)
exons 1–18
Sex/current age F-2.3y F-10y F- sudden death, 10y M-1.3y F-6.5y M-2.2y M-17y
Birth weight and age of gestation 3.3 kg, 37 wks 2.2 kg, 32 wks 2.0 kg, 32 wks 2.18 kg, 36 wks 3.2 kg, 39 wks 2.4 kg, 38 wks 2.37 kg, 37 wks
Neurological features
Global dev. delay þ þ þ þ þ þ þ
Speech delay þ þ (Sign language) þ (Sign language) þ þ þ þ
Neonatal hypotonia þ (Axial, stiff
extremities)
þ þInfantile, then mild þSignificant þ þ (Axial, stiff
extremities)
?
Craniofacial features
Skull abnormality Craniosynostosis,
microcephaly
Craniosynostosis Recurrent
craniosynostosis
(Large AF) – Plagiocephaly,
microcephaly
Microcephaly
Bitemporal narrowing þ þ þ þ þ þ þ
Broad nasal tip þ þ þ þ þ þ þ
Large/low set/posteriorly
rotated ears
þ/þ/þ þ/þ/(þ) þ/þ/(þ) /þ/þ // /þ/þ //þ
Thin upper lip þ þ (tented) þ (tented) þ (tented) þ (tented) þ þ
DT corners mouth þ þ þ þ (þ) Triangular mouth 
Other features
Cardiac defect/ Method of closure PDA, ASD/ Surgery PDA, ASD/ Catheter PDA, PFO/ Spontaneous
closure
PDA, ASD,
VSD/ Surgery
ASD sec, PDA/ Catheter  ?
Feeding problems þ þ þ þ  þ 
Eye problems  Ptosis, strabismus Ptosis, strabismus Nasolacrimal stenosis Strabismus, suspected CVI Limited fixation,
suspected CVI
Strabismus,
hypermetropia
Other features 5th clinodactyly
3 hemangiomata
Widely spaced nipples
Pre-auricular pits Hypospadias
Pre-auricular pits
Widely spaced nipples
Peg-shaped teeth
Epicanthal folds,
L single transverse palmar
crease,
Right Sydney crease
5th clinodactyly
Bilateral single
palmar creases
Broad eyebrows,
Crowded, abnormally
shaped teeth
þ, present; , absent or investigation not performed; ?, no information available; F, female; M, male; AF, anterior fontanelle; DT, down-turned; PDA, patent ductus arteriosus; ASD, atrial septal defect; PFO, patent foramen
ovale; VSD, ventricle septum defect; CVI, cortical visual impairment; L, left; 5th clinodactyly, clinodactyly of the fifth finger bilaterally.
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Figure 2. Pedigrees of the Families with KAT6A Mutations with Individual Results of Sanger Sequencing
Pedigrees and KAT6A Sanger sequencing traces (A–E; with reverse strand in B) or array-CGH findings (F) in all families with KAT6Amu-
tations. Squares denote males and circles denote females. Blackened symbols represent the affected children. The generation numbers
are shown to the left and individual identification numbers are shown underneath the symbols.Syndrome (MIM 176270). In individual 1 and 6, the hypo-
tonia was clearly axial with hypertonicity in the legs. In
five individuals, a primary issue during infancy and child-
hood was feeding difficulties. Three required a gastrostomy
tube (subjects 2, 3, and 6), one was fed by nasogastric tube
(subject 4) and the last was flask fed with severe difficulties
(subject 1). Individual 4 had a bilateral brain hemorrhage
grade II demonstrated by neurosonogram at age 7 days.
This was resolved, and at 3.5 months brain magnetic reso-
nance imaging (MRI) was normal.
Brain MRI was performed on six individuals (subjects 1–
6) and showed variable non-specific abnormalities in three
(see Table S1 for details). Further, seizures were present in
two individuals. First, in individual 6 as transient infantile
spasms that responded well to ACTH, which could later be
discontinued. Second, subject 3 presented at age 9 with sei-
zures and EEG changes (Table S1).
Five KAT6A mutation carriers had skull abnormalities.
Microcephaly (occipital frontal circumference; OFC% 3rd
centile) was found in subjects 1, 6, and 7. Craniosynostosis
of various typeswaspresent in four individuals. The severity510 The American Journal of Human Genetics 96, 507–513, March 5differedwith onlymetopic suture closure not requiring sur-
gical correction in subject 1, a squamous and slight inferior
coronal craniosynostosis requiring two separate repair pro-
cedures in subject 2, a sagittal craniosynostosis requiring
surgery and secondary metopic and sagittal recurrence
requiring additional surgery in subject 3, andplagiocephaly
in subject 6. In addition, subject 4 had a large anterior
fontanel.
Several individuals also had eye problems. Strabismus
was evident in four children (subjects 2, 3, 5, and 7). Indi-
vidual 3 was treated with patching and subject 5 with
botox. Poor vision was found in three children with sus-
pected cortical visual impairment in two (subject 5 and
6) and hypermetropia in one (subject 7). Ptosis requiring
surgical correction was present in subject 2 and 3. Finally,
Individual 4 had surgery due to nasolacrimal stenosis.
Global developmental delay was apparent in all individ-
uals during the first year of life. The two youngest stood
with support at 21 and 26 months of age, respectively,
and four subjects walked independently starting at the
ages of 17.5, 21, 36, and 36 months of age. An expressive, 2015
AB
C
D
Figure 3. Genetic Location and Functional Consequences of Detected KAT6A Mutations
(A) Schematic human chromosome 8. A vertical red line indicates the position of KAT6A at 8p11.21.
(B) A zoomed depiction of the KAT6A locus with a schematic illustration of exons (vertical black bars). The genetic position of all of the
five KAT6A point mutations is marked by black arrows.
(C) A schematic illustration of the main functional units of human KAT6A: the nuclear localization domain (H15), a double-plant ho-
meodomain finger (PHD), a histone-acetyl-transferase domain (HAT) containing a C2H2 zinc-finger domain (light blue), and an Acetyl-
coenzyme-A-binding domain (yellow); an acidic glutamate/aspartate-rich domain and a transactivation domain with both a serine-rich
(red) and a methionine-rich (green) region are also shown. The truncated KAT6A forms are shown below.
(D) The relative position of the truncated KAT6A in mutant mouse (MozD).11language disorder was present in all, with a better non-ver-
bal than verbal communication. The twin girls from family
2 communicated fully through sign language at age 10
years while individual 5 spoke 4- to 5-word sentences at
age 6. The full extent of the cognitive disability in KAT6A
mutation carriers will need to be further evaluated, as the
affected individuals grow older. The limited data available
today show that the two 10 year olds reached the approx-
imate cognitive level of 5 years. However, the oldest indi-
vidual (individual 7), with a heterozygous whole-gene
deletion, showed only mild intellectual disability and
was able to follow mainstream school with extra help.
Finally, discreet but overlapping facial features were
evident. All had a broad nasal tip, bitemporal narrowing,
a thin upper lip, and/or a tented mouth. Other common
but variable features were low-set posteriorly rotated ears,
smooth philtrum, down-turned corners of the mouth,
and mild micrognathia (Figure 1; Table 1, Table S1).
KAT6A, also known as MOZ or MYST3, is located on
chromosome 8p11 and was first identified as a fusion pro-
tein in individuals with acute myelogenous leukemia.4 The
full-length gene comprises 18 exons (16 coding) and has at
least three major splice forms that differ in their 50 UTR,
but all encode a protein 2004 amino acids in size. KAT6A
contains several important functional domains: a nuclearThe Amelocalization domain (including H15), a double-plant ho-
meodomain finger that binds to acetylated histone H3 tails
(PHD 1 and 2), a histone-acetyl-transferase domain (HAT),
an acidic glutamate/aspartate-rich region, and a serine and
methionine-rich region that comprises a transactivation
domain4–7 (Figure 3).
In humans, KAT6A is expressed in 49 out of 79 tissues
analyzed in the human protein atlas including brain
(high) and heart (low). The protein forms part of a histone
acetyltransferase complex that acetylates lysine-9 residues
in histone H3 (H3K9). Acetylated H3K9 is associated with
transcriptionally active genes, whereas histone deacetyla-
tion is associated with transcriptional silencing. In this
way, the KAT6A complex regulates a multitude of genes
including the developmental Hox genes and is important
for homeotic regulation.8
In zebrafish, kat6a is expressed in the head and is
required for normal development of pharyngeal segments
and for neural stem cell renewal.8–10 In rodents, Kat6a is
required for normal development of the thymus, the he-
matopoietic system, and the skeleton, and it is expressed
in most tissues both in the embryo and in the adult
mouse.8,11,12 Further, mice heterozygous for a C-terminal
deletion similar in size to that found in our families
(Figure 3) displayed an intermediate phenotype comparedrican Journal of Human Genetics 96, 507–513, March 5, 2015 511
to the homozygous andwild-type pups as regards the num-
ber and function of hematopoietic progenitor cells, as well
as the expression of Hox genes, showing that the KAT6A
effect is dosage-dependent.8,11
A dosage-dependent mechanism is further supported by
individual 7 in our study. He had a deletion of the entire
KAT6A gene and displayed similar facial manifestations
and symptoms to the subjects with truncating mutations,
supporting the notion that haploinsufficiency of KAT6A is
the cause of the phenotype in our subjects. All other
detected mutations reported here cluster in exon 17 and
18, affecting the acidic glutamate/aspartate-rich region
and truncating the protein at an amino-acid position
somewhere between residue 1039 and 1439, resulting in
loss of 29%–52% of the protein (Figure 3). Hence, the
HAT domain is not directly affected by these KAT6Amuta-
tions. However, the human C-terminal region (amino acid
1039–2004) is highly conserved in multiple species with
55% overall identity to that of zebrafish; 85%–87% to
chicken, mouse, and cow and 92% identity to dog (data
not shown; Clustal Omega). Several important domains
are located within this region including the transactivation
domain of KAT6A. Unfortunately samples were not avail-
able from our subjects for mRNA or protein analysis, thus
we could not determine whether or not the truncated
mRNA was subject to nonsense mediated mRNA decay
(NMD). Of note, the mice heterozygous for a C-terminal
deletion of Kat6a comprising amino acid 1538–2003
(Figure 3) showed normal levels of mRNA but KAT6A was
not detectable, suggesting a deficient translation or protein
instability.11
Further highlighting the importance of the C-terminal
region is a recent study that summarized 62 unrelated
individuals with mutations in KAT6B, demonstrating
that 89% of all mutations in KAT6B are truncating muta-
tions located in the similar C-terminal region.13 This
KAT6A paralogue has a 60% overall amino-acid sequence
identity to KAT6A and causes two different ID syn-
dromes: genitopatellar syndrome (MIM 606170) or Ohdo
syndrome/Say-Barber-Biesecker-Young-Simpson syndrome
(MIM 603736).14–16
Our subjects display some differences in their pheno-
typic presentation. However, phenotypic variation is
expected because KAT6A encodes a histone-acetylating
component of a multi-protein complex that will be prone
to genetic, epigenetic, and environmental modifiers. Inter-
estingly, in the report by Voss et al., the murine phenotype
was dependent on both genetic and environmental fac-
tors, the first shown by the additive effect of co-expression
of Tbx1 haploinsufficiency (MIM 602054) on the pheno-
type of Kat6a heterozygote mice, the second by fact that
up to 42% of apparently healthy pups heterozygous for
a C-terminal deletion of Kat6a developed severe cardiac
anomalies, cleft palate, and thymic aplasia upon exposure
to retinoic acid.17
In conclusion, after WES, array CGH, and careful clinical
characterization, we propose that heterozygous truncating512 The American Journal of Human Genetics 96, 507–513, March 5mutations in KAT6A, as well as deletions of the same locus,
cause a syndrome characterized by intellectual disability,
craniosynostosis, cardiac defects, feeding difficulties, and
distinct facial features. Additional subjects and func-
tional studies will be needed to further delineate this rare
disorder.Accession Numbers
The ClinVar accession numbers for the mutations in KAT6A
reported in this paper are SCV000196161, SCV000196746,
SCV000196511, SCV000196512, and SCV000196513.Supplemental Data
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